NURS-6630N Final Exam NURS-6630N
Final Exam
Mrs. Rosen is a 49-year-old patient who is experiencing fibro-fog. What does the PMHNP
prescribe for Mrs. Rosen to improve this condition?
Selected
Answer:
D.
All of the
...
NURS-6630N Final Exam NURS-6630N
Final Exam
Mrs. Rosen is a 49-year-old patient who is experiencing fibro-fog. What does the PMHNP
prescribe for Mrs. Rosen to improve this condition?
Selected
Answer:
D.
All of the
above
An elderly woman with a history of Alzheimer’s disease, coronary artery disease, and
myocardial infarction had a fall at home 3 months ago that resulted in her receiving an
open reduction internal fixation. While assessing this patient, the PMHNP is made aware
that the patient continues to experience mild to moderate pain. What is the PMHNP most
likely to do?
Selected
Answer:
A.
Order an X-ray because it is possible that she
dislocated her hip.
The PMHNP is caring for a patient who reports excessive arousal at nighttime. What could
the PMHNP use for a time-limited duration to shift the patient’s brain from a hyperactive
state to a sleep state?
Selected
Answer:
B.
Benzodiazepi
• Question 3
1 out of 1 points
• Question 2
0 out of 1 points
• Question 1
1 out of 1 points• Question 4
1 out of 1 points
nes
A patient addicted to heroin is receiving treatment for detoxification. He begins to
experience tachycardia, tremors, and diaphoresis. What medication will the PMHNP
prescribe for this patient?
Selected
Answer:
D.
Clonidine
(Catapres)
The PMHNP prescribes gabapentin (Neurontin) for a patient’s chronic pain. How does the
PMHNP anticipate the drug to work?
Selected
Answer:
A.
It will bind to the alpha-2-delta ligand subunit of voltage-sensitive
calcium channels.
A patient with hypersexual disorder is being assessed for possible pharmacologic
treatment. Why does the PMHNP prescribe an antiandrogen for this patient?
Selected
Answer:
C.
It will block
testosterone.
Which statement best describes a pharmacological approach to treating patients for
impulsive aggression?
Selected
Answer:
D.
Opioid antagonists can be used to
reduce drive.
• Question 7
1 out of 1 points
• Question 6
1 out of 1 points
• Question 5
1 out of 1 pointsA 26-year-old female patient with nicotine dependence and a history of anxiety presents
with symptoms of attention deficit hyperactivity disorder (ADHD). Based on the
assessment, what does the PMHNP consider?
Selected
Answer:
A.
ADHD is often not the focus of treatment in adults with
comorbid conditions.
A patient with irritable bowel syndrome reports chronic stomach pain. The PMHNP wants
to prescribe the patient an agent that will cause irrelevant nociceptive inputs from the
pain to be ignored and no longer perceived as painful. Which drug will the PMHNP
prescribe?
Selected
Answer:
C.
Duloxetine
(Cymbalta)
Parents of a 12-year-old boy want to consider attention deficit hyperactivity disorder
(ADHD) medication for their son. Which medication would the PMHNP start?
Selected
Answer:
All of the above could potentially treat their
son’s symptoms.
Which of the following is a true statement regarding the use of stimulants to treat
attention deficit hyperactivity disorder (ADHD)?
Selected
Answer:
B.
Signal strength output is increased by dialing up the release of
dopamine (DA) and norepinephrine (NE).
Mr. Peterson is meeting with the PMHNP to discuss healthier dietary habits. With a BMI of
• Question 12
1 out of 1 points
• Question 11
1 out of 1 points
• Question 10
1 out of 1 points
• Question 9
1 out of 1 points
• Question 8
1 out of 1 points33, Mr. Peterson is obese and needs to modify his food intake. “Sometimes I think I’m
addicted to food the way some people are addicted to drugs,” he says. Which statement
best describes the neurobiological parallels between food and drug addiction?
Selected
Answer:
A.
There is decreased activation of the
prefrontal cortex.
A 72-year-old male patient is in the early stages of Alzheimer’s disease. The PMHNP
determines that improving memory is a key consideration in selecting a medication.
Which of the following would be an appropriate choice?
Selected
Answer:
D.
All of the
above
A patient is prescribed D-methylphenidate, 10-mg extended-release capsules. What
should the PMHNP include when discussing the side effects with the patient?
Selected
Answer:
C.
The medication can affect your blood
pressure.
The parents of a 7-year-old patient with ADHD are concerned about the effects of
stimulants on their child. The parents prefer to start pharmacological treatment with a
non-stimulant. Which medication will the PMHNP will most likely prescribe?
Selected
Answer:
A.
Stratt
era
The PMHNP is assessing a patient who has expressed suicidal intent and is now stating
that he is hearing voices and sees people chasing him. The PMHNP identifies these
symptoms to be associated with which of the following?
• Question 16
1 out of 1 points
• Question 15
1 out of 1 points
• Question 14
1 out of 1 points
• Question 13
1 out of 1 pointsSelected
Answer:
C.
“Bath salt”
intoxication
An 80-year-old female patient diagnosed with Stage II Alzheimer’s has a history of
irritable bowel syndrome. Which cholinergic drug may be the best choice for treatment
given the patient’s gastrointestinal problems?
Selected
Answer:
A.
Donepezil
(Aricept)
A 63-year-old patient presents with the following symptoms. The PMHNP determines
which set of symptoms warrant prescribing a medication? Select the answer that is
matched with an appropriate treatment.
Selected
Answer:
B.
Impairment in the ability to learn and retain new information is most
problematic, and an appropriate treatment option would be donepezil.
The PMHNP is caring for a patient with chronic insomnia who is worried about
pharmacological treatment because the patient does not want to experience
dependence. Which pharmacological treatment approach will the PMHNP likely select for
this patient for a limited duration, while searching and correcting the underlying
pathology associated with the insomnia?
Selected
Answer:
D.
Non-benzodiazepine
hypnotics
The PMHNP is performing a quality assurance peer review of the chart of another PMHNP.
Upon review, the PMHNP reviews the chart of an older adult patient in long-term care
facility who has chronic insomnia. The chart indicates that the patient has been receiving
hypnotics on a nightly basis. What does the PMHNP find problematic about this
documentation?
• Question 20
1 out of 1 points
• Question 19
1 out of 1 points
• Question 18
1 out of 1 points
• Question 17
1 out of 1 pointsSelected
Answer:
B.
Hypnotics have prolonged half-lives that can cause drug
accumulation in the elderly.
The PMHNP is evaluating a 30-year-old female patient who states that she notices pain
and a drastic change in mood before the start of her menstrual cycle. The patient states
that she has tried diet and lifestyle changes but nothing has worked. What will the
PMHNP most likely do?
Selected
Answer:
C.
Prescribe desvenlafaxine (Pristiq), 50
mg daily
The PMHNP is caring for a patient with fibromyalgia. Which second-line treatment does
the PMHNP select that may be effective for managing this patient’s pain?
Selected
Answer:
C.
Imipramine
(Tofranil)
The PMHNP is assessing a patient she has been treating with the diagnosis of chronic
pain. During the assessment, the patient states that he has recently been having trouble
getting to sleep and staying asleep. Based on this information, what action is the PMHNP
most likely to take?
Selected
Answer:
A.
Order hydroxyzine (Vistaril), 50 mg PRN or
as needed
The PMHNP is attempting to treat a patient’s chronic insomnia and wishes to start with an
initial prescription that has a half-life of approximately 1–2 hours. What is the most
• Question 24
1 out of 1 points
• Question 23
1 out of 1 points
• Question 22
1 out of 1 points
• Question 21
1 out of 1 pointsappropriate prescription for the PMHNP to make?
Selected
Answer:
A.
Triazolam
(Halcion)
A patient with gambling disorder and no other psychiatric comorbidities is being treated
with pharmacological agents. Which drug is the PMHNP most likely to prescribe?
Selected
Answer:
D.
Naltrexo
ne
The PMHNP has been asked to provide an in-service training to include attention to the
use of antipsychotics to treat Alzheimer’s. What does the PMHNP convey to staff?
Selected
Answer:
D.
Both “A” & “C.”
A 14-year-old patient is prescribed Strattera and asks when the medicine should be
taken. What does the PMHNP understand regarding the drug’s dosing profile?
Selected
Answer:
B.
The patient will have one or two
doses a day.
Naltrexone (Revia), an opioid antagonist, is a medication that is used for which of the
following conditions?
Selected
Answer:
A.
Alcoholis
m
• Question 28
1 out of 1 points
• Question 27
1 out of 1 points
• Question 26
1 out of 1 points
• Question 25
1 out of 1 pointsKevin is an adolescent who has been diagnosed with kleptomania. His parents are
interested in seeking pharmacological treatment. What does the PMHNP tell the parents
regarding his treatment options?
Selected
Answer:
A.
“Naltrexone may be an appropriate option
to discuss.”
The PMHNP is caring for a patient with chronic insomnia who would benefit from taking
hypnotics. The PMHNP wants to prescribe the patient a drug with an ultra-short half-life
(1–3 hours). Which drug will the PMHNP prescribe?
Selected
Answer:
C.
Triazolam
(Halcion)
A patient recovering from shingles presents with tenderness and sensitivity to the upper
back. He states it is bothersome to put a shirt on most days. This patient has end stage
renal disease (ESRD) and is scheduled to have hemodialysis tomorrow but states that he
does not know how he can lie in a recliner for 3 hours feeling this uncomfortable. What
will be the PMHNP’s priority?
Selected
Answer:
C.
Prescribe
lidocaine 5%
The PMHNP wants to use a symptom-based approach to treating a patient with
fibromyalgia. How does the PMHNP go about treating this patient?
Selected
Answer:
C.
Matching the patient’s symptoms with the malfunctioning brain circuits
and neurotransmitters that might mediate those symptoms
• Question 32
1 out of 1 points
• Question 31
1 out of 1 points
• Question 30
1 out of 1 points
• Question 29
1 out of 1 pointsThe PMHNP is caring for a patient who openly admitted to drinking a quart of vodka daily.
Prior to prescribing this patient disulfiram (Antabuse), it is important for the PMHNP to:
Selected
Answer:
A.
Evaluate the patient’s willingness to abstain
from alcohol
A 9-year-old female patient presents with symptoms of both attention deficit
hyperactivity disorder (ADHD) and oppositional defiant disorder. In evaluating her
symptoms, the PMHNP determines that which of the following medications may be
beneficial in augmenting stimulant medication?
Selected
Answer:
C.
Guanfacine ER
(Intuniv)
An adult patient presents with a history of alcohol addiction and attention deficit
hyperactivity disorder (ADHD). Given these comorbidities, the PMHNP determines which
of the following medications may be the best treatment option?
Selected
Answer:
C.
Atomoxetine
(Strattera)
The PMHNP prescribes an obese patient phentermine (Adipex-p)/topiramate ER
(Topamax) (Qsymia), Why is topiramate (Topamax) often prescribed with phentermine
(Adipex-P)?
Selected
Answer:
B.
Phentermine (Adipex-P) works by suppressing appetite while
topiramate (Topamax) acts by inhibiting appetite.
• Question 36
1 out of 1 points
• Question 35
1 out of 1 points
• Question 34
1 out of 1 points
• Question 33
1 out of 1 pointsThe PMHNP evaluates a patient presenting with symptoms of dementia. Before the
PMHNP considers treatment options, the patient must be assessed for other possible
causes of dementia. Which of the following answers addresses both possible other causes
of dementia and a rational treatment option for Dementia?
Selected
Answer:
A.
Possible other causes: hypothyroidism, Cushing’s syndrome,
multiple sclerosis
Possible treatment option: memantine
The PMHNP is assessing a patient who presents with elevated levels of brain amyloid as
noted by positron emission tomography (PET). What other factors will the PMHNP
consider before prescribing medication for this patient, and what medication would the
PMHNP want to avoid given these other factors?
Selected
Answer:
D.
Both “A” &
“B”
The PMHNP is discussing dopamine D2 receptor occupancy and its association with
aggressive behaviors in patients with the student. Why does the PMHNP prescribe a
standard dose of atypical antipsychotics?
Selected
Answer:
C.
The doses are based on achieving 60% D2
receptor occupancy.
The PMHNP is caring for a patient who experiences too much overstimulation and anxiety
during daytime hours. The patient agrees to a pharmacological treatment but states, “I
don’t want to feel sedated or drowsy from the medicine.” Which decision made by the
PMHNP demonstrates proper knowledge of this patient’s symptoms and appropriate
treatment options?
Selected A.
• Question 40
1 out of 1 points
• Question 39
1 out of 1 points
• Question 38
1 out of 1 points
• Question 37
0 out of 1 points• Question 41
1 out of 1 points
Answer: Avoiding prescribing the patient a drug that blocks
H1 receptors
Which patient will receive a lower dose of guanfacine?
Selected
Answer:
D.
Patient with kidney
disease
A patient diagnosed with obsessive compulsive disorder has been taking a high-dose
SSRI and is participating in therapy twice a week. He reports an inability to carry out
responsibilities due to consistent interferences of his obsessions and compulsions. The
PMHNP knows that the next step would be which of the following?
Selected
Answer:
A.
Decrease his SSRI and add buspirone
(Buspar).
The PMHNP is teaching parents about their child’s new prescription for Ritalin. What will
the PMHNP include in the teaching?
Selected
Answer:
A.
The second dose should be taken
at lunch.
The PMHNP is assessing a patient who will be receiving phentermine (AdipexP)/topiramate (Topamax) (Qsymia). Which of the following conditions/diseases will require
further evaluation before this medication can be prescribed?
Selected
Answer:
C.
Cardiovascular
disease
• Question 45
• Question 44
1 out of 1 points
• Question 43
1 out of 1 points
• Question 42
1 out of 1 pointsA group of nursing students seeks further clarification from the PMHNP on how
cholinesterase inhibitors are beneficial for Alzheimer’s disease patients. What is the
appropriate response?
Selected
Answer:
D.
Both “A” &
“C.”
The PMHNP is assessing a 49-year-old male with a history of depression, post-traumatic
stress disorder (PTSD), alcoholism with malnutrition, diabetes mellitus type 2, and
hypertension. His physical assessment is unremarkable with the exception of peripheral
edema bilaterally to his lower extremities and a chief complaint of pain with numbness
and tingling to each leg 5/10. The PMHNP starts this patient on a low dose of doxepin
(Sinequan). What is the next action that must be taken by the PMHNP?
Selected
Answer:
A.
Orders liver function
tests.
The PMHNP is attempting to treat a patient’s chronic pain by having the agent bind the
open channel conformation of VSCCs to block those channels with a “use-dependent”
form of inhibition. Which agent will the PMHNP most likely select?
Selected
Answer:
A.
Pregabalin
(Lyrica)
A patient with chronic insomnia asks the PMHNP if they can first try an over-the-counter
(OTC) medication before one that needs to be prescribed to help the patient sleep. Which
is the best response by the PMHNP?
Selected
Answer:
D.
“You can get melatonin over the counter, which will help
with sleep onset.”
The PMHNP wants to prescribe Mr. Barber a mood stabilizer that will target aggressive
• Question 49
1 out of 1 points
• Question 48
1 out of 1 points
• Question 47
1 out of 1 points
• Question 46
1 out of 1 points
1 out of 1 pointsand impulsive symptoms by decreasing dopaminergic neurotransmission. Which mood
stabilizer will the PMHNP select?
Selected
Answer:
A.
Lithium
(Lithane)
The PMHNP is meeting with the parents of an 8-year-old patient who is receiving an initial
prescription for D-amphetamine. The PMHNP demonstrates appropriate prescribing
practices when she prescribes the following dose:
Selected
Answer:
A.
The child will be prescribed
2.5 mg.
Mrs. Kenner is concerned that her teenage daughter spends too much time on the
Internet. She inquires about possible treatments for her daughter’s addiction. Which
response by the PMHNP demonstrates understanding of pharmacologic approaches for
compulsive disorders?
Selected
Answer:
D.
“There are no evidence-based treatments for Internet addiction, but
there are behavioral therapies your daughter can try.”
A 43-year-old male patient is seeking clarification about treating attention deficit
hyperactivity disorder (ADHD) in adults and how it differs from treating children, since his
son is on medication to treat ADHD. The PMHNP conveys a major difference is which of
the following?
Selected
Answer:
D.
Comorbidities are more common in adults, impacting the prescription
of additional agents.
A 71-year-old male patient comes to an appointment with his 65-year-old wife. They are
both having concerns related to her memory and ability to recognize faces. The PMNHP is
considering prescribing memantine (Namenda) based on the following symptoms:
• Question 53
1 out of 1 points
• Question 52
1 out of 1 points
• Question 51
1 out of 1 points
• Question 50
1 out of 1 points• Question 55
1 out of 1 points
Selected
Answer:
C.
Amnesia, apraxia,
agnosia
When completing this exam, did you comply with Walden University’s Code of
Conduct including the expectations for academic integrity?
Selected Ye
Answer: s
The PMHNP is working with the student to care for a patient with diabetic peripheral
neuropathic pain. The student asks the PMHNP why SSRIs are not consistently useful in
treating this particular patient’s pain. What is the best response by the PMHNP?
Selected
Answer:
B.
“SSRIs only increase serotonin
levels.”
The PMHNP is treating a patient for fibromyalgia and is considering prescribing
milnacipran (Savella). When prescribing this medication, which action is the PMHNP likely
to choose?
Selected
Answer:
C.
Split the daily dose into two doses after
the first day.
A patient is being prescribed bupropion and is concerned about the side effects. What will
the PMHNP tell the patient regarding bupropion?
Selected
Answer:
C.
It can cause cardiac
arrhythmias.
• Question 57
1 out of 1 points
• Question 56
1 out of 1 points
• Question 54
0 out of 0 pointsWhat will the PMHNP most likely prescribe to a patient with psychotic aggression who
needs to manage the top-down cortical control and the excessive drive from striatal
hyperactivity?
Selected
Answer:
C.
Antipsychot
ics
The PMHNP understands that slow-dose extended release stimulants are most
appropriate for which patient with ADHD?
Selected
Answer:
A.
8-year-old
patient
The PMHNP prescribed a patient lamotrigine (Lamictal), 25 mg by mouth daily, for nerve
pain 6 months ago. The patient suddenly presents to the office with the complaint that
the medication is no longer working and complains of increased pain. What action will the
PMHNP most likely take?
Selected
Answer:
A.
Increase the dose of lamotrigine (Lamictal) to 25
mg twice daily.
The PMHNP is selecting a medication treatment option for a patient who is exhibiting
psychotic behaviors with poor impulse control and aggression. Of the available
treatments, which can help temper some of the adverse effects or symptoms that are
normally caused by D2 antagonism?
Selected
Answer:
D.
Second-generation, atypical
antipsychotics
• Question 62
1 out of 1 points
• Question 61
1 out of 1 points
• Question 60
1 out of 1 points
• Question 59
1 out of 1 points
• Question 58
1 out of 1 pointsA 75-year-old male patient diagnosed with Alzheimer’s disease presents with agitation
and aggressive behavior. The PMHNP determines which of the following to be the best
treatment option?
Selected
Answer:
D.
Citalopram (Celexa) or Escitalopram
(Lexapro)
An 8-year-old patient presents with severe hyperactivity, described as “ants in his pants.”
Based on self-report from the patient, his parents, and his teacher; attention deficit
hyperactivity disorder (ADHD) is suspected. What medication is the PMNHP most likely to
prescribe?
Selected
Answer:
A.
Methylphenidate (Ritalin,
Concerta)
The PMHNP is providing a workshop for pediatric nurses, and a question is posed about
noradrenergic agents to treat ADHD. Which of the following noradrenergic agents have
norepinephrine reuptake inhibitor (NRI) properties that can treat ADHD?
Selected
Answer:
D.
Both “A” &
“C”
A patient with chronic back pain has been prescribed a serotonin-norepinephrine
reuptake inhibitor (SNRI). How does the PMHNP describe the action of SNRIs on the
inhibition of pain to the patient?
Selected
Answer:
A.
“The SNRI can increase noradrenergic neurotransmission in the
descending spinal pathway to the dorsal horn.”
An opioid-naive patient is taking MS Contin (morphine sulfate) to treat his pain that is
• Question 66
1 out of 1 points
• Question 65
1 out of 1 points
• Question 64
1 out of 1 points
• Question 63
1 out of 1 pointssecondary to cancer. Under what circumstances would the PMHNP order naloxone
(Narcan) IM/SQ?
Selected
Answer:
D.
The patient’s vital signs are 98.4F temp, 88 pulse, 104/62 blood
pressure, and 8 respirations.
Why does the PMHNP avoid prescribing clozapine (Clozaril) as a first-line treatment to the
patient with psychosis and aggression?
Selected
Answer:
A.
There is too high a risk of serious adverse
side effects.
The PMHNP understands that bupropion (Wellbutrin) is an effective way to assist patients
with smoking cessation. Why is this medication effective for these patients?
Selected
Answer:
C.
Bupropion (Wellbutrin) blocks dopamine reuptake, enabling more
availability of dopamine.
An 18-year-old female with a history of frequent headaches and a mood disorder is
prescribed topiramate (Topamax), 25 mg by mouth daily. The PMHNP understands that
this medication is effective in treating which condition(s) in this patient?
Selected
Answer:
A.
Migrain
es
The PMHNP is teaching a patient with a sleep disorder about taking diphenhydramine
(Benadryl). The patient is concerned about the side effects of the drug. What can the
PMHNP teach the patient about this treatment approach?
Selected
Answer:
B.
“It can cause blurred
• Question 70
1 out of 1 points
• Question 69
1 out of 1 points
• Question 68
1 out of 1 points
• Question 67
1 out of 1 points• Question 71
1 out of 1 points
vision.”
A patient with fibromyalgia and major depression needs to be treated for symptoms of
pain. Which is the PMHNP most likely to prescribe for this patient?
Selected
Answer:
Duloxetine
(Cymbalta)
A young patient is prescribed Vyvanse. During the follow-up appointment, which
comment made by the patient makes the PMHNP think that the dosing is being done
incorrectly?
Selected
Answer:
B.
“I am unable to fall asleep
at night.”
A patient with chronic insomnia and depression is taking trazodone (Oleptro) but
complains of feeling drowsy during the day. What can the PMHNP do to reduce the drug’s
daytime sedating effects?
Selected
Answer:
C.
Give the medicine at night and
lower the dose
A PMHNP supervisor is discussing with a nursing student how stimulants and
noradrenergic agents assist with ADHD symptoms. What is the appropriate response?
Selected
Answer:
D.
All of the
above.
• Question 75
1 out of 1 points
• Question 74
1 out of 1 points
• Question 73
1 out of 1 points
• Question 72
1 out of 1 pointsThe PMHNP is assessing a female patient who has been taking lamotrigine (Lamictal) for
migraine prophylaxis. After discovering that the patient has reached the maximum dose
of this medication, the PMHNP decides to change the patient’s medication to zonisamide
(Zonegran). In addition to evaluating this patient’s day-to-day activities, what should the
PMHNP ensure that this patient understands?
Selected
Answer:
D.
This medication has unwanted side effects such as sedation, lack of
coordination, and drowsiness.
The PMHNP is caring for a patient on risperidone (Risperdal). Which action made by the
PMHNP exhibits proper care for this patient?
[Show More]
Last updated: 3 years ago
Preview 1 out of 19 pages